drugset / Trial / NCT02051673
Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)
Summary
Four subjects were treated under compassionate use provisions under this study with facilitating cell therapy (FCRx)
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | FCRx | Cell therapy | — | — |